Your leading voice in digital health news
Twitter X Logo

Accessible pathway to CRISPR/Cas9

26 February 2026
By Dawn O'Shea
The CRISPR licensing company ERS Genomics has announced the launch of its Early Access Express License initiative, a new licensing option designed to support early stage innovators at pre-seed and pre-revenue stage seeking access to the foundational CRISPR/Cas9 patent portfolio at the earliest stages of development. In a statement, the company said “the Early Access […]

Subscribe to read more

Pulse+IT website access

Keep your finger on the pulse with full access to all articles published on pulseit.news
Instant access
All articles
Cancel anytime

Your leading voice in digital health news

Twitter X

Your leading voice in digital health news 

Keep your finger on the pulse with full access to all articles published on 
pulseit.news
Subscribe from only $39
magnifiercrossmenuchevron-down